These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 15112272)

  • 21. [Skip metastasis to the mediastinal lymph nodes in non-small cell lung cancer].
    Wang S; Wu Y; Ou W
    Zhonghua Zhong Liu Za Zhi; 2001 May; 23(3):259-61. PubMed ID: 11783103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance.
    Rena O; Carsana L; Cristina S; Papalia E; Massera F; Errico L; Bozzola C; Casadio C
    Eur J Cardiothorac Surg; 2007 Dec; 32(6):863-7. PubMed ID: 17936004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic significance of surgical-pathologic N1 lymph node involvement in non-small cell lung cancer.
    Demir A; Turna A; Kocaturk C; Gunluoglu MZ; Aydogmus U; Urer N; Bedirhan MA; Gurses A; Dincer SI
    Ann Thorac Surg; 2009 Apr; 87(4):1014-22. PubMed ID: 19324121
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
    Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIB-1, p53, bcl-2, and WAF-1 expression in pelvic lymph nodes and primary tumors in early stage cervical carcinomas: correlation with clinical outcome.
    Graflund M; Sorbe B; Karlsson M
    Int J Oncol; 2002 May; 20(5):1041-7. PubMed ID: 11956602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status.
    Maeshima AM; Tsuta K; Asamura H; Tsuda H
    Cancer; 2012 Sep; 118(18):4512-8. PubMed ID: 22282325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathologic N1 non-small cell lung cancer: correlation between pattern of lymphatic spread and prognosis.
    Marra A; Hillejan L; Zaboura G; Fujimoto T; Greschuchna D; Stamatis G
    J Thorac Cardiovasc Surg; 2003 Mar; 125(3):543-53. PubMed ID: 12658196
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lobe-specific skip nodal metastasis in non-small cell lung cancer patients.
    Kawano R; Hata E; Ikeda S; Yokota T
    Ann Thorac Cardiovasc Surg; 2008 Feb; 14(1):9-14. PubMed ID: 18292733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic relevance of skip metastases in esophageal cancer.
    Prenzel KL; Bollschweiler E; Schröder W; Mönig SP; Drebber U; Vallboehmer D; Hölscher AH
    Ann Thorac Surg; 2010 Nov; 90(5):1662-7. PubMed ID: 20971285
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Involvement of lymphatic metastatic spread in non-small cell lung cancer accordingly to the primary cancer location.
    Kotoulas CS; Foroulis CN; Kostikas K; Konstantinou M; Kalkandi P; Dimadi M; Bouros D; Lioulias A
    Lung Cancer; 2004 May; 44(2):183-91. PubMed ID: 15084383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53 as a new prognostic factor for lymph node metastasis in penile carcinoma: analysis of 82 patients treated with amputation and bilateral lymphadenectomy.
    Lopes A; Bezerra AL; Pinto CA; Serrano SV; de MellO CA; Villa LL
    J Urol; 2002 Jul; 168(1):81-6. PubMed ID: 12050497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An immunohistochemical study of p21 and p53 expression in primary node-positive breast carcinoma.
    O'Hanlon DM; Kiely M; MacConmara M; Al-Azzawi R; Connolly Y; Jeffers M; Keane FB
    Eur J Surg Oncol; 2002 Mar; 28(2):103-7. PubMed ID: 11884043
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epidermal growth factor receptor, cyclooxygenase-2, and BAX expression in the primary non-small cell lung cancer and brain metastases.
    Milas I; Komaki R; Hachiya T; Bubb RS; Ro JY; Langford L; Sawaya R; Putnam JB; Allen P; Cox JD; McDonnell TJ; Brock W; Hong WK; Roth JA; Milas L
    Clin Cancer Res; 2003 Mar; 9(3):1070-6. PubMed ID: 12631609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Altered retinoblastoma protein expression in nonsmall cell lung cancer: its synergistic effects with altered ras and p53 protein status on prognosis.
    Dosaka-Akita H; Hu SX; Fujino M; Harada M; Kinoshita I; Xu HJ; Kuzumaki N; Kawakami Y; Benedict WF
    Cancer; 1997 Apr; 79(7):1329-37. PubMed ID: 9083154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathologic lymph node staging practice and stage-predicted survival after resection of lung cancer.
    Osarogiagbon RU; Allen JW; Farooq A; Berry A; O'Brien T
    Ann Thorac Surg; 2011 May; 91(5):1486-92. PubMed ID: 21524460
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Frequency of noncontiguous lymph node involvement in patients with resectable nonsmall cell lung carcinoma.
    Bonner JA; Garces YI; Sawyer TE; Gould PM; Foote RL; Deschamps C; Lange CM; Li H
    Cancer; 1999 Oct; 86(7):1159-64. PubMed ID: 10506699
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Prognosis and prognostic factor after extended lymphadenectomy in lung cancer].
    Sakao Y; Hata E; Miyamoto H; Harada R; Hamada T
    Nihon Kyobu Geka Gakkai Zasshi; 1997 May; 45(5):711-7. PubMed ID: 9170862
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein overexpression and gene amplification of epidermal growth factor receptor in nonsmall cell lung carcinomas. An immunohistochemical and fluorescence in situ hybridization study.
    Suzuki S; Dobashi Y; Sakurai H; Nishikawa K; Hanawa M; Ooi A
    Cancer; 2005 Mar; 103(6):1265-73. PubMed ID: 15712203
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases.
    McKay JA; Douglas JJ; Ross VG; Curran S; Ahmed FY; Loane JF; Murray GI; McLeod HL
    Clin Cancer Res; 2000 Mar; 6(3):1113-8. PubMed ID: 10741741
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
    Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
    Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 52.